Loading company…
Schrodinger develops physics-based software for molecular discovery and design in drug and materials research.
Founded in 1990 and based in New York, US, Schrodinger develops computational software for molecular research. Its tools support drug discovery, biologics development, and materials science for academic and pharmaceutical users. The company sells software licenses and subscriptions, and reported revenue of USD 207.54 mn in fiscal year 2024. It raised USD 202 million in its February 2020 IPO.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in